• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: DEPUY MITEK / ANIKA THERAPEUTIC, INC. MONOVISC 88MG/4ML; ACID, HYALURONIC, INTRAARTICULAR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

DEPUY MITEK / ANIKA THERAPEUTIC, INC. MONOVISC 88MG/4ML; ACID, HYALURONIC, INTRAARTICULAR Back to Search Results
Device Problem Output Problem (3005)
Patient Problem Pain (1994)
Event Type  Injury  
Event Description
Pt reported he is in pain due to delay with delivery to mdo.Pt also reported he was hospitalized.(b)(6).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
MONOVISC 88MG/4ML
Type of Device
ACID, HYALURONIC, INTRAARTICULAR
Manufacturer (Section D)
DEPUY MITEK / ANIKA THERAPEUTIC, INC.
MDR Report Key12348464
MDR Text Key267721999
Report NumberMW5103374
Device Sequence Number1
Product Code MOZ
UDI-Device Identifier59676082001
UDI-Public59676082001
Combination Product (y/n)Y
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Voluntary
Reporter Occupation Pharmacist
Type of Report Initial
Report Date 08/17/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received08/19/2021
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator No Information
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was Device Evaluated by Manufacturer? No Information
Type of Device Usage N
Patient Sequence Number1
Patient Outcome(s) Hospitalization;
-
-